4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000004
Chief Commercial Officer sold 2,932 shares at $27.09 ($79,428)
- Chief Commercial Officer acquired 6,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Milanova Tsveta · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,000 | 32,122 | D | ||
| 2025-12-30 | Sale : show line 2 in the form 10b5-1 | −2,932 | $27.09 | $79,428 | 29,190 | D |
| Open-market sales · 2,932 sh · avg $27.09 · $79,428 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-30 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −6,000 | 0 | D |
Loading xslF345X05/wk-form4_1767402899.xml…